Elanco Animal Health (ELAN) announced the U.S. Department of Agriculture approval of TruCan Ultra Lyme-L4. It is the first and only 1/2 mL combination vaccine protecting against both Lyme disease and leptospirosis, all in a low-volume dose, for dogs. This combination formulation allows veterinarians to provide essential protection without the need for multiple injections.
The approval follows recent USDA approvals of TruCan Ultra B, and TruCan Ultra CIV H3N2/H3N8. TruCan Ultra Lyme-L4 is expected to begin shipping in the next 30 days.
In pre-market trading on NYSE, Elanco Animal Health shares are up 0.52 percent to $24.30.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.